Renin can be detected in cardiovascular and other tissues but it disappears after bilateral nephrectomy indicating that tissues can take up or bind renal renin from the circulation. If renin uptake is the result of specific binding, plasma prorenin may be a natural antagonist of tissue directed renin-angiotensin systems.
SEALFY ET AL
Because prorenin appears to have highly localized effects, we proposed that it might bind to tissues.'0 Circulating renin may also bind to tissues. Infused renin is taken up by vascular tissues."," Renin has been extracted from cardiovascular tissues from intact,'3,'4 but not from bilaterally nephrectomized,15 rats, indicating that the source of renin in the vascula. ture is the kidneys. When they discovered renin, Tigerstedt and BergmanI observed that the pressor effects of renal extracts last for only minutes in intact rabbits, but for hours in bilaterally nephrectomized rabbits. Such rabbits might have vacant binding sites for renin. Other studies suggest that tissue-directed renin might be catalytically active.17 The evidence for regulated uptake of renin has been strengthened by the recent demonstration of binding of extrinsically labeled "?-renin to membranes from rat mesenteric arteries." It is not known if prorenin binds to the same site.
By binding to the same site as renin, prorenin would be a natural antagonist of tissue directed plasma renin-angiotensin systems. Such an effect might explain the association of the high prorenin levels of pregnancy and diabetes mellitus with vasodilation' and the positive relationship between prolonged exposure to high prorenin levels in teenage diabetic patients and hyperperfusion injury. '9*20 In this study we searched for evidence of prorenin and renin binding in a variety of rat tissues. To avoid potential artifacts, intrinsically labeled recombinant rat prorenin was used. To avoid underestimation of the binding capacity of the various tissues, endogenous renin was removed from all membrane preparations.
MATERIALS AND METHODS

Buffers
Bufier I fir Renin Assay This buffer was 50 mmol/L Tris-Cl, pH 7.4, containing 0.1 mol/ L NaCl, 0.5% bovine serum albumin (BSA), 0.1% EDTA, and O.lYo NaN,. This buffer was incubated at 56°C for 0.5 h to denature any contaminants in the BSA, and stored at 4°C.
Buffer 11 for Prurenin Activutim
This buffer was 0.5 mol / L Tris-Cl, pH 7.5, 5 mm01 / L CaCl,, and 1 lo BSA.
Buffer III for Men&mne Prepamtion and Dihtion
This buffer was 10 mmol/ L Tris-Cl, pH 7.& containing 10 mmol / L MgCl,, 1 mmol / L KCl, 0.1% EDTA, and 0.1%
NaNB
Buffer IV This was buffer IX1 with the addition of 0.3 mol / L sucrose.
Bluffer V for Dilution of Ligunds This buffer was 50 mmol/L phosphate, pH 7.5, 0.5% BSA, 0.1% EDTA, 0.1% NaN,, 0.05% phenylmetbylsulfonyl fluoride U'MSF), and 0.057% 8-OH-quinoline.
Bufier VI for LXalysis of Provenin This buffer was 50 mmol/ L sodium phosphate, pH 7.5, 100 mmol/ L NaCl, 0.1% EDTA, and 0.1% NaN-, .
Buffer H fur Prorenin Purifi~?~tion This buffer was 50 nrmol / L Tris-Cl, pH 8.0 containing 0.1 mol /L NaCl, 0.1% EDT& 0.1% NaN?, and 10 mmol/ L benzamidine.
Preparation of Rat Renin Secreting GH, Ceils (GH-RR)
Rat renin cDNA coding sequences" were amplified by polymerase chain reaction (PCR) using the primers 5'-CGAAGCTTCCATGGGCGGGAGGAG-GATG-3' and 5'-GATCCTTAGCGGGCCAAGGC AA&3'. The amplified cDNA fragment was inserted into the SlnaI site of the expression vector pEE14. The resulting rat renin (rREN) expression vector was tiansfected into a GH4 cell line." Although the vector pEEi contains a selectable maker for glutamine syntbetase resistance,?" it proved difficuit to maintain stable transformants using methionine sulfoxime (the antibiq:i.c that is degraded by glutamine synthase) _ Ths;efoie, cells were cotransfected with pRSV-Neo and selecte&& GQ18 resistance as described by Chu et al.*' Transformants were maintained in the presence of 200 pg /mL G418.
The clone selected for production and labeling of prorenin (G&-RR) produced at least 50,000 ng angiotensin I (AI)/mL/ h per 24 h (0.5 kg prorenin/mL) when started at about 50% confluence in fresh Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS ) .
Preparation of Recombinant Rat Prcrenin
The final product of renin gene expression in G&-RR cells is prorenin. For hrge-scale purification, cells were maintained at, or near confluence in 175 cm* flasks containing DMEM plus 10% FBS. Media were cleared of cell debris by centrifugation at 2,700 g for 10 min at 20°C.
For the production of 3'S-prorenin, labeling was performed using cells that were plated 24 h beforehand, and grown to 40% to 50% confluence in DMEM plus 10% FBS. The cells were then rinsed with methioninefree DMEM containing 10% dialyzed FBS and incubated in this medium for 3 h. The medium -was replaced with DMEM containing 10% dialyzed FBS, 5 mCi j5S-methionine (1005 Ci /mmol) and 3 pg /mL cold methionine (10% of the usual concentT+ation). After 18 h incubation, the medium was collected and centrifuged to remove cell debris. Free '?&methionine was removed by ultrafiltration using a 2.2 mL Amicon centricon 0'M30), adding 3 X 2 mL aliquots of Dulbecco's phosphate buffered saline (DPBS) and reducing the volume lo-fold after each addition.
Preparation
of an Anti-Rat Prorenin Prosequence IgG Affinity Column
The &amino acid prosequence of rat prorenin [CSFSLPTDTASFGRILLKKMPSVREIL-EERGVDMTRISAEWGEFIKKI was synthesized (Im-munodynamics, Menlo Park, CA) and used to innoculate rabbits (Immunodynamics) IgG from rabbit IR 657 was purified by affinity chromatography with Protein A Sepharose according to recommendations of the manufacturer (Pharmacia, Uppsala, Sweden). The purified IgG was then coup!ed to CNBr-activated Sepharose again following the manufacturer's recommendations (Pharmacia) . An affinity precolumn was prepared bv omitting the antibodv from the coupling reaction.
Affinity Purification of Recombinant Rat prorenin
above. The precoiumn flow-throug'h, which colitained
Nonradioactive Prorenin
Medium from GH&R celIs was precipitated with 65% ammonium sulfate to conprorenin, was loaded at 0.1 mL/min direct!y onto a centrate the starting material 20-to 50-fold. The precipitate was dialyzed against buffer H and loaded onto the 100 mL immunoaffinity column and the flow-through ZOO mL CnBr precolumn without antibody described I and 20 FL TPCK treated trypsin (3.0 mg /mL in buffer II) (Sigma) and the mixture incubated at room temper-1 ature for 30 min. The reaction was stopped by adding 30 ,uL soybean trypsin inhibitor (6 mg /mL in 0.1 mol / Intrinsic renin activity was determined in samples L NaCl). The renin activity so formed was measured by an enzyme kinetic assay followed by radioimm.unothat were treated similarly but not exposed to trypsin. s.ssay (RIA) of the angiotensin I, as follows: to 120 p,c;L P of the activated sample were added, 100 @L buffer 1, 2 rorenin /*L 5% PMSF, 2 PL 5.7% 8-hydroxyquinolone (angiotenwas calculated as the difference between the sinase inhibitors) and 35 to 100 FL nephrectomized rat plasma (a source of angiotensinogen to provide a final concentration of 1 p,g AI equivalents/mL)
. The sample was incubated for 1 h at 0°C and 37°C. The generated AI was measured by RIA." The results are expressed as nanograms AI /milliliters /hour after subtraction of the Al in the samule incubated at 0°C was monitored at AZw. The immunoaffinity column was :vashed with buffer H until the A,,, was either zero or constant (approximately 10 bed volumes). Prorenin was then eluted with 0.2 mol / L glycine, pH 3.0. The fractions with the highest prorenin concentration were pooled, dialyzed against buffer VI, and then stored at -40°C. Pure rat renin was generated from prorenin by trypsin activation as described below uxder "Measurement of Prorenin and Renin."
35S-Labeled Prorenin and Kenin
The ammonium sulfate step was omitted. For purifications using the anti-rat prosequence antibody, cell culture medium was diluted 1: 4 (v:v) with buffer H and then loaded onto a 10 mL precolumn. The precolumn effluent was loaded directly onto the immunoaffinity cohnnn. The precolumn was disconnected, and the affinity column was washed with buffer H until the radioactivity in the flow-through was less than 8000 counts /min/mL. Prorenin was then eluted with 0.2 mol / L glycine, pH 3.0. Fractions with the highest counts/minute were pooled, dialyzed against buffer VI, and stored at -40°C. The specific activity of the radioactive rat prorenin was determined by measuring the enzymatic activity (see below) of an aliquot of trypsin-cleaved prorenin and counting the same volume.;pecific activity ranged from 500 to 1500 counts imin / fmol of enzy_matic activity assuming that 100 ng AI/mL / h is equivalent to 1 ng/mL renin in our assay ( see below).
j5S-Renin was prepared from ?+prorenin by incubating it with 500 pg /mL of N-tosyl-L-phenylalanine chloromethyl ketone (TI'CK)-treated trypsin (Sigma, St. Louis, MO) at 0°C for 1 11. The reaction was stopped by incubation with 1000 .ug /mL soybean trypsin inhibitor for 15 min at room tempenVare. renin a,:tivities in the trypsin and nontrypsin activated samples.
Plasma prorenin was measured by a similar assay except that the plasma was passed over Dowex25 after trypsin activation (4 mg/mL) to remove angiotensinogen fragments.*' Plasma renin was measured similarly except that trypsin was omitted from the activation step.
Gel Elechophoresis of Recombkant
Rat Prorenin Rat prorenin was subjected to 12% sodium dodecyl sulfate (SDS) polyacrylamide gel electrcphoresis (Biorad, Richmond, CA, or Novex, San Diego, CA, gel apparatus with precast gels) and transferred to a nitrocellulose membrane. Prorenin was detected by Western blcrc with the rabbit ant&rat prorenin prosequence antibody (IR657) and alkaline phosphatase-labeled goat anti-rabbit IgG and by silver staining. Two dimensional olectro&oFe;is of ~=I-~holod Vl'C"L,.L prorenin was performed with fr;initube gels (5iorad) for isoelectric focusing (IEF) and the second dimension was performed with a 12% slab gel. Deglycosylation of N-linked carbohydrate was performed with PNGaseF and EndoH (New England Biolabs, Beverly, MA) using 1250 units of enzyme per sample and buffers provided by the manufacturer.
Membrane Preparation
Unanesthetized 200 to 300 g normal rats were decapitated. Their organs were removed, washed with iced saline, weighed, and frozen at -40°C. Unless otherwise stated, all steps were perfonned at 4°C. Ice chilled buffer IV, 4 mL / g wet tissue, was added. Tissue was homogenized on ice for 30 set (twice at speed 10 and once at speed 6; Polytron, Brinkmann Instruments, Westbury, NY) and centrifuged at 2,000 g for 30 min. The supernatant was centrifuged at 15.000 P for 30 min. The 15,000 2 supematant was then Measurement of Prorenin and Renin Prorenin was &t&ged again at 100,oCO g fo; 7O*min. The 100,000 g converted to renin during incubation with trypsin as pellet was suspended in 4 volumes of buffer III per origifollows. To 10 PL sample were added to 90 PL buffer nal gram of tissue and centrifuged again at 100,000 g .
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TO remove renin from the membranes, the pellet was incubated for 1 h on ice with 1 volume of 4 mol/ L M&12. *' Finally, the membranes were washed twice with 5 volumes of buffer III and centrifuged at 100,OOOg. If residual renin activity remained higher than 10 ng AI/h/ 50 @g protein, membranes were reextracted with 4 mol/L M&12. Membranes were stored at -40°C. Protein concentration was determined by Lowry assay*' using BSA as the standard.
Binding Assays At first, the binding assay was performed in 5 mL tubes in a total volume of 3nO &. Later, to conserve on membranes and ligand, the volume was reduced to 150 HL (identica! concentrations) and incubated in 1.5 mL microcentrifuge tubes. Either 100 PL or 50 PL aliquots each of membranes (50 pg or 25 fig microsomal membrane protein in buffer III), radioligand (70 to 100 pmol/L in buffer V), and, if appropriate, competitor ligand were mixed gently on ice. Tubes were then incubated at 4°C for 18 h to reach equilibrium. Nonspecific binding (NSB) was defined by the addition of lo-' mol/L prorenin (final concentration) or 3 x 10-s mol / L renin. In pilot NSB experiments, purified prorenin was compared to ammonium sulfate precipitated crude prorenin. Identical results were obtained. Therefore, unless stated otherwise, ammonium sulfate precipitated prorenin or renin was used to determine nonspecific binding. The binding assay was terminated by adding 2 mL (300 PL assay) or 1 mL (150 ILL assay) ice chilled buffer III followed by centrifugation at 2800 rpm, 4"C, for 20 min (300 PL assay), or in a tabletop microfuge at 12,000 rpm for 5 min (150 pL assay). The wash and centrifugation step were repeated once. The pellet was resuspended in 20 PL 4 mol / L urea and counted in a Packard scintillation counter after adding 5 mL Atomlight scintillation fluid (Dupont-NEN, Boston, MA). Data were analyzed by the weighted nonlinear least squares modeling methods of Deiean and Lefkowitzz9 Dissociation constants were averaged as geometric means and ranges were calculated.x
The ligands for competition binding experiments were purified rat renin or prorenin, partially activated human prorenin 143% prorenin, 57% renin, the generous gift of Dr. Robert Heinrikson (Upjohn, Kalamazoo, MI)],si rat,3* and human angiotensinogen,33 isoleucine and valine-5 angiotensin I and II, gonadotropin releasing hormone (GnRHl, insulin, and atria1 natrluretic factor (ANF) (all from Peninsula Laboratories Inc.), amylase, BSA, hemoglobin, heparin, lysozyme, ovalbumin, cytochrome C, pepsin, pepsinogen, ribonuclease A, mannose-6 phosphate, and a-methyl d-mannoside (all from Sigma Chemical), rat prorenin prosequence peptide (Immunodynamics, La Jolla, CA), rerun inhibitor 30697 (Squibb, Princeton, NJ), and antibody to the hog renin binding protein (the generous gift of Dr. Fukamizu) , Kinetics of F'rorenin Clearance In Vivo Male Sprague-Dawley rats (Hilltop Laboratory Animals, Inc., Scottdale, PA) weighing 240 to 250 g were used. T,;e experimental procedures were approved by the Cornell University Institutional Animal Care and Use Committee. Rats were anesthetized with metofane (n:;:!hoxyflurane, Pitman-Moore, Inc., Mundelein, IL), both kidneys were gently removed to minimize excessive release of rerun. C!earance studies were carried out 16 to 30 h after bilateral nephrectomy. Intact (n = 1) or nephrertomzed (x = 3) rats were anesthetized with peniobarbiiol ( 53 mg /kg, intraperitoneally 1 and placed oii a thcrmaregulated heating pad (Hamilton Indusri+es, Cncianati, OH). They were tracheostomized, and a I'E 50 catheter was inserted in the right carotid artery to monitor arterial blood pressure. W 10 catheters were placed into both jugular veins for drug administration and maintenance of anesthesia (pentobarbitol, 9 mg/mL at 1.8 pL/min). Fluid loss associated with surgery was replaced with 1 mL of isotonic saline. After blood pressure stabilized, the tail tip was cut and the first blood samples collected. An intravenous bolus of 7 PL prorenin (400 ng, 40,OOn ng AI/h enzyme activity) was then administered im qe jugular vein followed by 50 FL isotonic saline. One hundred microliter blood samples were collected fro:m the tail 2, 4, 8, 16, 32 , and 64 min after prorenin injection.
Total plasma renin (prorenin + renin j and Tlasma renin concentrations were measured as described above and plasrn~ prorenin was calculated by subtracting plasma renin from plasma total renin. The decay of plasma prorenin with time was analyzed using the PC-NONLIN kinetic modeling package (Scientific Consulting, Apex, NC) and fitted to a two-compartment mode1.34,35
RESULTS
Preparation of Prorenin
Purified rat prorenin electrophoresed on a 12% SDS polyacrylamide gel as a doublet composed of a major band of M, approximately 46,000 and a minor band of slightly higher molecular weight (Figure 1Al . "S-Methionine-labeled rat prorenin also displayed a similar doublet ( Figure 1B) . When deglycosylated with the mannose-specific N-linked endoglycosidase EndoH or the nonspecific endoglycosidase PNGaseF, prorenin appeared to decrease in molecular weight on an SDS gel and to lose the upper faint band ( Figure 1B) . This result provides' strong evidence that the GH4 cell prorenin is a mannose-containing glycoprotein similar to CHO cell human prorenin?6 Two dimensional gel electrophoresis of the labeled material further resolved five major and two minor discrete species, suggesting varying levels of posttranslational modification (Figure lC) , a result that has previously been observed for endogenous renin by others.'7-'9 Enzymatic specific activity of the purified rat prorenin, determined by measuring the enzymatic activity of a known mass of trypsin-cleaved prorenin in the presence of 1 pmol/L angiotensinogen (usually 1 pg of AJH-MAY 1996-VOL. 9 Initial experiments showed that ?S-prorenin bound specifically to rat renal cortical membranes. An incubation temperature of 0" to 4°C was used to avoid potential proteolytic effects and to decrease nonspecific binding, which increased above 4°C (Figure 2) . The pH optimum for binding was between 7.0 and 7.5. There was an abrupt fall in binding below pH 6.0, and a more gradual decline above pH 7.5. Pretreatment of membranes at 56°C caused a sharp decrease in prorenin binding to less than 10% of control values with both renal cortex (1C.l 2 0.51 fmol/mg) and liver membranes (5.3 t 0.58 fmol/ mg). Our studies revealed a very slrw association rate at 0" to 4°C of approximately 15 h at 100 pmol / L ligand and 30 pmol / L receptor concentration. Off-rate kinetics displayed a half-life greater than 24 h at 0°C.
PRORENINIRENIN BINDING IN RAT TISSUES 495
A Survey of Prorenin Binding to Various Tissues
To survey dilferences in the tissue biding, microsomal membranes were prepared from a variety of rat tissues, and binding experiments were performed at a fixed, nonsaturating concentration of 35s prorenin ( 70 pm01 As shown in Figure 3 , there were differences in binding between tissues. Relative binding was highest in the renal cortex (55 fmol /mg), I+Y (54 fmol /mg), and testes 63 (fmol/mg), intermediate in lung 131 fmol/mg), brain (18 fmol/mgf, renal medul!a (15 fmol/mg), and adrenal gland (17 fmol/mg), low in aorta (7 fmol/mg) ar.d heart (4 fmol/mg), and very low in skeletal muscle (1 fmol /mg) . Although these measurements are a function of both the biding affinity and the number of sites available for binding, the affinities 06 the sites in liver, kidney and heart are similar (see &:ow). Therefore, these measurements prorenin (Figure 7 ). Mathematical modeling of the experimental rcsrrlts suggested that a two-compartment model best fit the data. V, averaged 643 mL / kg (range 554 to 712 mL/ kg) in three nephrectomized rats and 476 mL / kg in an intact rat. The total apparent volume of distribution (V,) averaged 1132 (range: 988 to 1404) mL /kg and 924 mL / kg, respectively.
DISCUSSION
In the present study we identify a high affinity binding site for renin and prorenin in membranes from rat tissues. We propose to name the site ProBP. Binding was highly specific. Bound prorenin was displaced only by related proteins (rat prorenin > rat renin > human prorenin) while numerous other potential ligands had no effect. Binding capacity was highest in renal cortex, liver, and testes, intermediate in lung, brain, adrenal gland, and renal medulla, low in heart and aorta, and almost undetectable in skeletal muscle. The demonstration of a specific binding site for renin supports the results of many investigators who have suggested that renin is taken up by tissues."-i4,r7,i* The results indicate that renin may be actively taken up by both renal and extrarenai tissues and that the extent of binding differs markedly between organs.
Although our studies did not specifically address the question of whether renin is active when bound, renin activity was consistently detected in renal membrane preparations and could be removed only by treatment with 4 mol / L MgClr . It is therefore likely that renin is active when bound. A tissue binding site may serve as a buffer for acute changes in renin, acting as a renin reservoir, or may be a new locus at which blood pressure may be regulated. Tissue binding of renin and localized angiotensin production might explain why spontaneously hypertensive rats (SHR) respond !a blockade of the renin system despite having normal circulating renin levels.4* Renal renin binding may also explain why a dose of an angiotensin antagonist that is too low to have an effect when infused into the peripheral circulation lowers systemic BP in the SHR when infidsed intrarenally. 4' These results also provide the first evidence for specific prorenin binding. They are consistent with our hypothesis that prorenin has a localized effect.g The observation that prorenin is inactive when bound may explain prorenin's putative vasodilator action9 since NO. 5 occupancy of binding sites by inactive prorenin would diminish renin uptake thereby limiting the capacity of tissue-bound renin to generate the vasoconstrictor hor mane angiotensin II. This interpretation is consistent with the premise tha; prorenln is a natural antagonist of tissue-directed renin-angiotensin systems. Alternatively, we may have identified a prorenin / renin receptor that, when activated, rnay transduce an as yet unidentified intracellular event. knowledge concerning prorenin. Infusion of prorenin is associated with only minor falls in blood pressure,*' indicating that renin and prorenin binding are not likely to be high in resistance vessels. The very low degree of binding to aorta and skeletal muscle is consistent with that premise. High prorenin levels are associated with increased blood flow to kidneys" and reproductive organs,z consistent with the high Icvels of binding we found in kidneys and testes. High adrenal binding is also not unexpected. Like the kidneys and testes, the adrenal glands express the prorenin gene4 and transgenic rats with excessive adrenal renin gene expression secrete large amounts of prorziin and adrenal steroids into the circulation,45 raising the intriguing possibility that adrenal prorenin / renin uptake may have effects on steroid production. Preliminary studies reported herein demonstrated a high volume of distribution of exogenously administered recombinant prorenin in rats (greater than the extracellular fluid volume) indicating that sigkficant amounts of renin and prorenin may be sequestered in organs with high binding capacities. Hiruma et al similarly observed a very hQh v0:im.n of distribution for infused rat renal renin.3" The proreninirenin binding capacity of renal cortex is 200 fmol /mg membranal protein,, the yield of which was close to 1% of the tissue mass. Therefore, a renal cortex of 0.5 g (0.S mL), containing approximately 5 mg of membranes, is likely to have 1000 fmol (2 nmol/ Lf bi~lding sites. A plasma retin concentration of 5 ng/mL / h with 4-fold m-,re prorenin than renin would result in a combined renin and prorenin concentration of 5 pmol/ 1. A binding site with a Kd of 200 pmol/L would be no more than 2.5% occupied, 2% by prorenin and 0.5% by renin, meaning that it would zgntain in the range of 5 fmol or 25 ng AI/h of renin activity. This would result in tissue renin levels of 10 fmoli mL (50 ng /mL / h f , five times the normal circulating concentration. In the vicinity of the qlomerulus, where renin and prorenin are secreted. the renin concentration is likely to be much higher than in blood. Such renal renin binding may help to explain the very high levels of angiotensin II that have been measured in renal cortical compartments.'"s*7
There are marked dif&'ences in !h~ binding site described herein and those reported by Campbell and Valentijn,'s which may be explained hy differences prorenin. They carried out binding at 37"C, a tempera ture at which we found high levels of nonspecific binding (Figure 2 ). They did not investigate the effect of prorenin so we do not know if prorenin binds to the site they identified. Because sufficient unlabeled rat renin was not available they were not clearly able to show saturable binding, except indirectly. There were ma@r differences in tissue distribution of binding sites. They found the highest binding in mesenteric arteries, a major resistance bed, low levels in aorta, lung, and renal medulla, and no binding in renal cortex, a site where we found the highest levels. We found very low binding in the aorta and did not test the mesenteric artery. Beside the differeni'e in the probe, we removed all endogenous renin from membranes by pretreatment with MgCl,. Occupancy by endogenous renin or prorenin in the Campbell and Velentijn study may have masked other binding sites in the tissues in which we detected the greatest degree of binding. A binding protein for renin, called "renin binding protein" (RnBP), has been cloned and identified?8 The data accumulated so far indicate that RnBP is unlikely to be responsible for the binding observed in our studies. RnBP is found predominantly in cytosol ?9 AJH-MAY 1996VCX 9, NO. 5 Prorenin is not a &and o'ersonai communication, 3r.
Miyake).
RnBP ml?.NA is undetectable in liver extracts,= a site at which we observed high levels of specific binding. To distinguish the factor identified herein from RnBP we propose to use the acronym ProBP.
Binding sites have been demonstrated for other circulating enzymes and proenzymes, eg, thrombin5' and p1asminogen.s' ln some instances, as with plasminogen, binding is not associated with an intracellular event. In others, as with thrombin, the enzyme cleaves a portinn of the binding site, which then leads to the transduction of a signal. So far we have no evidence that prorenin / renin binding transduces a secondary intracellular or membranal event. Multiple possible responses could potentially occur following prorenin / renin binding. These include second messenger production, internalization and processing of the l&and, receptor endocytosis, and desensitization.
CONCLUSIONS
In summary, specific binding of renin has been demonstrated in rat tissues. Since the same site also binds prorenin we have termed it ProBP to distinguish it from RnBP. ProBP binding capacity differs between tissues indicating that prorenin/ renin uptake may be regulated differently in various organs and that changes in binding could determine the activity of putative tissue renin angiotensin systems. These results also identify a role for prorenin. By competing for binding, or by transducing an intracellular signal, prorenin may be the natural antagonist of tissue-directed renin-angiotensin systems. That would explain the association of high prorenin levels with renal vasodilation' and its presence in reproductive organs, which maintain extraordinarily high blood flows. It might also explain the development of diabetic vascular disease subsequent to hyperperfusion injury,"," which occurs in patients with high plasma prorenin lavels.
